| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 04/02/2002 | CA2051012C Carbocyclic adenosine analogs useful as immunosupressants |
| 03/28/2002 | WO2002024698A1 Xanthine phosphodiesterase v inhibitors |
| 03/28/2002 | WO2001077075A3 Inhibitors of inflammation and reperfusion injury |
| 03/28/2002 | WO2001064676A3 INHIBITORS OF p38-α KINASE |
| 03/28/2002 | WO2001049687A3 Cyclohexene nucleic acids |
| 03/28/2002 | WO2001045686A3 Formulations of adenosine a1 agonists |
| 03/28/2002 | WO2000066102A3 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 03/28/2002 | US20020037886 Muscarinic agonists |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1081624C Benzamide analogs, useful as PARP (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 03/26/2002 | US6362180 Antagonist to corticotropin releasing factor |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002000659A3 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 03/21/2002 | WO2001081346A3 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/21/2002 | US20020035252 Purine inhibitors of cyclin dependent kinase 2 & IkBa |
| 03/21/2002 | US20020035117 Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives displaying inhibitory activities on type five phosphodiesterase |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP0970074B1 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration |
| 03/20/2002 | CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof |
| 03/19/2002 | US6358963 For therapy of viral infections |
| 03/19/2002 | CA2206804C Trisubstituted thioxanthines |
| 03/14/2002 | WO2002020484A1 Chemical compounds |
| 03/14/2002 | WO2001047918A3 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides |
| 03/14/2002 | WO2001045684A3 Formulations of adenosine a1 agonists |
| 03/14/2002 | US20020032327 Purine inhibitors of cyclin dependent kinase 2 & IkappaBalpha |
| 03/14/2002 | DE10042655A1 Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion Process for the preparation of inhibitors of cell adhesion |
| 03/13/2002 | EP1185517A1 Antibiotic prodrugs |
| 03/13/2002 | CN1340054A 2-amino-6-anilino-purines and their use as medicaments |
| 03/13/2002 | CN1339967A Composition for treatinb obesity and aesthetic treating method |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355726 Multicomponent ugi reaction; antisense agents, antigens; diagnosis; controlling gene expression by polymeric peptide nucleic acids |
| 03/12/2002 | US6355646 Immunology treatment of inflammatory conditions and immune disorders septic shock |
| 03/07/2002 | WO2002018384A1 Process for the preparation of vitronectin receptor antagonists |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028842 Reducing the vomiting side effects of phosphodiesterase inhibitors, e.g. Rolipram, Ariflo, by benzylation by benzyl bromide or a derivative |
| 03/07/2002 | US20020028823 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same |
| 03/07/2002 | DE10035928A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments |
| 03/06/2002 | EP1183256A1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/06/2002 | EP1183032A1 Method of enhancing insulin action |
| 03/06/2002 | EP0756595B1 Substituted 1,3-oxathiolanes with antiviral properties |
| 03/06/2002 | CN1080263C Method and compositions for the synthesis of dioxolane nucleosides with 'beta'-configuration |
| 03/05/2002 | US6352991 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| 03/05/2002 | US6352990 CRF receptor antagonists and methods relating thereto |
| 02/28/2002 | WO2001068600A3 Benzylated pde4 inhibitors |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | WO2000073307A8 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
| 02/27/2002 | EP1181291A2 Dna methyltransferase inhibitors |
| 02/26/2002 | US6350753 2-Substituted-4-substituted-1,3-dioxolanes and use thereof |
| 02/26/2002 | US6350752 Modulating purine derivatives such as guanosine, inosine pranobex and 4-(3-(1,6-dihydro-6-oxo-9-purin-9-yl) -1-oxopropyl)amino)benzoic acid (ait-082); inducing in vivo production of heme oxygenase to reduce blood pressure; |
| 02/26/2002 | US6350735 Purine derivatives |
| 02/19/2002 | US6348587 Purine or pyrimidine base derivatives; anticancer, antitumor and antiproliferative agents; treating hiv and hepatitis |
| 02/19/2002 | US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/19/2002 | US6348470 Alleviate cough with theobromine |
| 02/14/2002 | US20020019405 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010167A1 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 02/07/2002 | WO2002009701A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016333 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity |
| 02/07/2002 | US20020016329 Inhibit p34cdc2/cyclin Bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016309 Imidazopyridine and imidazopyrimidine antiviral agents |
| 02/07/2002 | CA2418121A1 Antimicrobial biaryl compounds |
| 02/07/2002 | CA2414623A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/06/2002 | EP1178046A1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 02/06/2002 | EP1177188A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 02/06/2002 | EP1176959A1 Novel prolines as antimicrobial agents |
| 02/06/2002 | EP0659082B1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 02/06/2002 | CN1334814A Antiviral nucleoside analogues |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 01/31/2002 | WO2002008834A1 Radiation sensitive compositions containing image quality and profile enhancement additives |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002008192A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 01/31/2002 | US20020013299 For enhancing the chemotherapeutic treatment of tumor cells in a mammal with an antineoplastic alkylating agent, which causes cytotoxic lesions at the O6-position of guanine; O6-alkylguanine-DNA alkyltransferase (AGT) inactivator |
| 01/30/2002 | EP1176146A1 Carbamoyl tetrahydropyridine derivatives |
| 01/30/2002 | EP1176145A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 01/30/2002 | EP1102782A4 Structural analogs of amine bases and nucleosides |
| 01/29/2002 | US6342603 Purine derivatives having cyclopropane ring |
| 01/29/2002 | US6342503 Antidepressants, eating disorders |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/24/2002 | US20020010360 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1- methanol |
| 01/24/2002 | US20020010333 Use of xanthine derivatives for reducing the pathological hyperreactivity of eosinophilic granulocytes, novel xanthine compounds and process for their preparation |
| 01/24/2002 | US20020010098 Insecticides, nematodicides |
| 01/24/2002 | US20020009748 Nucleobase heterocyclic combinatorialization |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | CN1332747A 2'-fluoronucleosides |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/22/2002 | US6340756 Process for preparing a 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/21/2002 | CA2353369A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/17/2002 | WO2002004452A2 Methods for treatment of disease-induced peripheral neuropathy and related conditions |